SEARCH

SEARCH BY CITATION

Keywords:

  • intraductal papillary mucinous tumor;
  • pancreas;
  • endoscopic ultrasound;
  • fine-needle aspiration biopsy;
  • cytology

Abstract

  1. Top of page
  2. Abstract
  3. MATERIALS AND METHODS
  4. RESULTS
  5. DISCUSSION
  6. REFERENCES

BACKGROUND

Intraductal papillary mucinous tumors (IPMT) account for 5% of pancreatic neoplasms. Preoperative identification is important because of their frequent multifocal or diffuse involvement in pancreatic ducts, which makes extensive surgery necessary even in benign cases. To the authors' knowledge, the cytologic features of this entity in fine-needle aspiration biopsy (FNAB) specimens have seldom been described and are poorly standardized.

METHODS

Eleven consecutive cases of surgically proven IPMT with previous endoscopic ultrasonography (EUS)-guided FNAB were collected for retrospective analysis. EUS-FNAB had been performed with on-site attendance of a cytopathologist in all cases. Macroscopic and microscopic appearance of mucin, cellular type and arrangement, presence of nuclear grooves, and degree of nuclear atypia were recorded.

RESULTS

Final diagnosis was benign IPMT (B) in four cases, borderline IPMT (Bo) in two cases, malignant IPMT (M) in one case, and IPMT associated with invasive carcinoma (Ca) in four. Retrospective analysis found moderate to high levels of extracellular mucin in 10 of the 11 cases. The other case (one Ca) showed a small amount of thick mucin. In all cases, epithelial cells were identified, although cellularity was very low in four cases (three B and one Bo). Atypia was absent in two cases (two B) slight in two cases (two B), moderate in three cases (one Bo and two Ca), and severe in four cases (one Bo, one M, and two Ca). Mucinous epithelium was found in nine cases and nonmucinous epithelium in five cases (one Bo and four Ca). Papillary structures were observed in five cases (two Bo and three Ca), sheets in eight cases (four B, one Bo, one M, and two Ca), single atypical cells in five cases (one Bo and four Ca), irregular clusters in three cases (one Bo and two Ca), and nuclear grooves in two cases (one B and one Bo).

CONCLUSIONS

The most common features of IPMT were extracellular mucin and sheets of mucinous epithelium. Papillae and nuclear grooves were not consistently found. Nonmucinous epithelium, severe atypia, single atypical cells, and irregular clusters indicated a high probability of malignant transformation. Even in the absence of atypia, a clinically significant diagnostic orientation can be established in most cases on the basis of the characteristic cytologic picture. Cancer (Cancer Cytopathol) 2005. © 2005 American Cancer Society.

Intraductal papillary mucinous tumors (IPMT) account for approximately 5% of pancreatic neoplasms,1 although this figure may in fact be an underestimation because the terminology has not been standardized.2 The term “IPMT” is applied to a spectrum of proliferative epithelial lesions ranging from hyperplasia to adenocarcinoma “in situ.” They have in common the production of large amounts of mucus, resulting in duct dilatation that can be detected by image techniques, particularly endoscopic ultrasonography (EUS). The involvement of the ductal system is frequently multifocal or diffuse, thus necessitating aggressive surgical procedures such as total pancreatectomy to eliminate the risk of development of an invasive adenocarcinoma.3, 4 Similarly, in cases with low-stage pancreatic adenocarcinoma in which a partial pancreatectomy is planned, the demonstration of an associated IPMT would modify the surgical approach.

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) is an excellent method for procurement of diagnostic samples from the pancreas, with a diagnostic accuracy of > 90% for pancreatic adenocarcinoma.5 EUS-FNAB allows placement of the needle inside the dilated ductal system, at several levels if necessary, to distinguish IPMT from other causes of duct dilatation such as obstruction or chronic pancreatitis. Although there are several reports in the literature on EUS diagnosis of IPMT,6–9 to our knowledge the value of FNAB in this setting has not been well established.10 In fact, the evaluation of the utility of EUS-FNAB is impaired by the scarcity of descriptions of the cytologic features of this entity. Those performed to date tend to be nonsystematic or based on a limited number of cases.11–15

The aim of the current study was to provide clues for a correct preoperative diagnosis of IPMT by EUS-FNAB, based on the cytologic findings in a series of 11 histologically proven cases.

MATERIALS AND METHODS

  1. Top of page
  2. Abstract
  3. MATERIALS AND METHODS
  4. RESULTS
  5. DISCUSSION
  6. REFERENCES

Between January 2002 and June 2003, 147 EUS-FNABs of the pancreas were performed at the Hospital Clinic in Barcelona, Spain. Of these, 11 cases with surgical resection and with a final pathologic diagnosis of IPMT were identified and are the subject of the current study. The interval between FNAB and surgery ranged from 4 days to 6 months. There were 8 males and 3 females, with a median age of 60 years and 81 years, respectively (range, 37–77 years). The main clinicopathologic features and the original cytologic diagnoses are shown in Table 1.

Table 1. Clinical Features, Original Cytologic Diagnosis, and Final Diagnosis
PatientAge (yrs)GenderLocationCytologic diagnosisHistopathologic diagnosis
  1. F: female; IPMT: intraductal papillary mucinous tumor; M: male; IMA: invasive mucinous adenocarcinoma; IDA: invasive ductal adenocarcinoma; MCN: mucinous cystic neoplasm.

172FHead-bodyMucinous neoplasmIPMT benign
277MHeadMucinous adenocarcinomaIPMT malignant and IMA
343MHeadMucinous neoplasmIPMT benign
437FHead-bodyMucinous adenocarcinomaIPMT malignant and IDA
556FHeadMCNIPMT benign
669MHeadIPMTIPMT borderline
755MHead-bodyMCNIPMT benign
862MHeadInconclusive atypiaIPMT borderline
974MHead-bodyIPMTIPMT malignant and IDA
1068MHeadMucinous neoplasmIPMT malignant and IDA
1156MHeadMucinous adenocarcinomaIPMT malignant

EUS-FNAB was indicated to study cystic or solid masses of the pancreas with or without dilatation of the ductal pancreatic system, previously detected by other imaging techniques. EUS was carried out under conscious sedation. Patients first underwent diagnostic imaging with a radial scanning echoendoscope at 7.5 megahertz (MHz) and 12 MHz (GF UM20, Olympus America Inc., Melville, NY), and further EUS FNAB was performed using a linear echoendoscope (GF UC30P, Olympus America) with a 22G, 8-cm long, Wilson Cook needle catheter assembly (Wilson-Cook Medical Inc., Winston-Salem, NC). FNABs were performed on cystic lesions in five cases, on dilated pancreatic duct in four cases, and on solid and cystic masses associated with duct dilatation in two cases. Because an attendant cytopathologist was present throughout the procedure for immediate evaluation of the sample, several needle passes were performed when necessary.

The aspirated material was smeared onto slides, part of which were air dried and stained with a rapid Romanowsky stain (Diagnostic Grifols SA, Barcelona, Spain) and the rest fixed in 96% alcohol for Papanicolaou stain. Fluid samples of > 1 mL were processed after centrifugation. Tissue fragments or clots were recovered and processed as cell blocks.

A retrospective analysis was performed on cytologic smears to examine the following features reported in previous descriptions of IPMT12, 14: quantity and density of mucus, amount of cellularity, presence or absence of mucinous and nonmucinous epithelium, papillae, sheets, irregular clusters, discohesiveness, nuclear grooves, psammomas, and degree of nuclear atypia.

RESULTS

  1. Top of page
  2. Abstract
  3. MATERIALS AND METHODS
  4. RESULTS
  5. DISCUSSION
  6. REFERENCES

Significant findings from the cytologic analysis are shown in Table 2. The quantity and thickness of the mucin varied. In most cases, it was evident on macroscopic inspection at the time of aspiration. It tended to be more fluid in benign cases, resulting in a slightly stained, diffuse background on smears.

Table 2. Cytomorphologic Features
Case1234567891011
  1. B: benign IPMT; Ca: IPMT associated with invasive carcinoma; Bo: borderline IPMT; M: malignant non-invasive IPMT.

Quantity of mucus++++++++++++++++++++++++++
Density of mucus+++++++++++++++++++++
Cellularity++++++++++++++++++++
Sheets++++++++
Papillae+++++
Irregular clusters+++
Single atypical cells+++++
Mucinous cells+++++++++
Nonmucinous cells+++++
Nuclear atypia++++++++++++++++++++
Nuclear grooves++
Final diagnosisBCaBCaBBoBBoCaCaM

Cellularity was more abundant in malignant cases. In most cases, cells were arranged in monolayered sheets. Well formed papillae with fibrovascular cores were not observed in any of our cases. Micropapillary clusters were seen only in borderline and malignant cases. Similarly, irregular clustering and discohesiveness with single atypical cells were features of borderline and malignant lesions (Fig. 1).

thumbnail image

Figure 1. Different morphologic features of epithelium in intraductal papillary mucinous tumors. (A) Nonmucinous micropapillae, (B) mucinous flat sheet, (C) irregular cluster with isolated atypical mucinous cells, and (D) transition from eosinophilic epithelium to honeycombed mucinous epithelium without atypia (Papanicolaou stain, original magnification × 400.)

Download figure to PowerPoint

Mucinous type epithelium was found in all but two cases (Fig. 2). In five cases, nonmucinous epithelium was observed, corresponding to malignant (four) or borderline (one) lesions. In three of these cases, the epithelium was distinctively eosiniphilic, with a similar appearance to duodenal mucosa. To rule out the possibility of needle track contamination, nonmucinous epithelium was recorded only in cases with cellular atypia or abnormal arrangement, usually micropapillary (Figs. 1A and 3).

thumbnail image

Figure 2. Case 7. Benign intraductal papillary mucinous tumor. (A) Sheet of mucinous epithelium without atypia. (B) Its counterpart in the surgical specimen (A: Papanicolaou stain; B: H & E). Original magnification ×400 (A); ×200 (B).

Download figure to PowerPoint

thumbnail image

Figure 3. Case 2. Intraductal papillary mucinous tumor associated with invasive ductal carcinoma. (A) Micropapillary cluster of highly atypical cells on a mucinous background. (B) Histopathology shows a papillary intraductal proliferation lined with eosinophilic epithelium containing goblet cells (A: Papanicoloau stain; B: H & E). Original magnificiaton ×400 (A); ×100 (B).

Download figure to PowerPoint

Cellular atypia correlated well with the final histopathologic diagnosis. Two benign cases demonstrated slight atypia. Nuclear grooves were prominent only in two cases. Neither nuclear inclusions nor psammoma bodies were found.

In summary, benign cases presented abundant but less thick mucin, and usually little mucinous cellularity. High cellularity, high mucus density, and micropapillary structures were features of malignant and borderline cases.

DISCUSSION

  1. Top of page
  2. Abstract
  3. MATERIALS AND METHODS
  4. RESULTS
  5. DISCUSSION
  6. REFERENCES

Intraductal proliferative lesions of the pancreas are controversial entities. Currently, terms such as pan-in, mucinous ectasia, mucinous cystic neoplasia, and IPMT still overlap.1, 2 Fortunately, the debate is usually confined to the definition of a given lesion in the surgical specimen. From a practical point of view, there is general agreement on the need to characterize lesions detected preoperatively as potentially dangerous or not. This approach would allow us to classify mucinous lesions as a group,16 regardless of the final diagnosis. Indeed, even with the whole specimen, the distinction of a macrocystic IPMT from a mucinous cystic neoplasm could ultimately be based on clinical data such as age, gender, and cyst location.2, 17

IPMT poses major clinical problems. Even when associated with an invasive component, the prognosis is better than for standard invasive adenocarcinoma.17, 18 Cure of these lesions requires radical surgery. A ductal dilatation detected by imaging techniques may be a benign change that does not need therapy, as is the case in chronic pancreatitis, or a lesion that will require total pancreatectomy. Previous reports on IPMT suggest that the issue is a simple one for the cytopathologist, because typical papillae and abundant thick mucin will be found.12, 14, 15 However, in the current series, the amount of mucin was small in some cases, or was very fluid and difficult to demonstrate in others. Furthermore, the papillary pattern was not obvious in many cases, and the epithelium was not always mucinous.

Some previous reports assumed that the cytologic features of IPMT parallel those of mucinous cystic neoplasms, and so did not systematically analyze the specific features of IPMT.12, 14 Others present somewhat conflicting results because of the small number of cases.11, 15 The largest series published so far identifies features of malignancy and invasion with a varied spectrum of sampling techniques,13 an approach of only limited use in a clinical setting such as EUS-FNAB. In a more recent series of EUS-FNAB, Maire et al.10 reported very poor results for specimens collected from dilated ducts. In the current series, most specimens were also obtained from cysts or duct dilatations and were adequate for diagnosis. The methods used by Maire et al. for specimen collection and processing are confusing, and may be the reason for the disappointing results. The lack of well defined diagnostic criteria also explains the low precision of the original cytologic diagnoses in our series (Table 1).

The amount and quality of mucin are crucial for the identification of this entity.12 Some have advocated the use of special stains to identify mucin objectively.14, 16 In our experience, thick mucin is easy to demonstrate on microscopic examination with routine stains, whereas very fluid mucin will produce a diffuse background that makes special stains useless, because its behavior is similar to that of the fluid originating in the gastrointestinal lumen in EUS-FNAB procedures. Macroscopic examination of the fluid, and ideally the presence of the cytopathologist in the exploration room during the procedure, would help to clarify the issue. Nevertheless, the identification of a nearly watery fluid as mucin is too subjective and cannot be the sole basis for an important decision. Biochemical analysis of the fluid for viscosity, mucin proteins, and tumor markers is reported to be of help,14, 19–21 although the results are not entirely specific and may be controversial. We did not perform biochemical analysis systematically. In the current series, all cases yielded epithelium and we believe that, when the mucinous nature of the fluid is not absolutely obvious, the evaluation of the cellular component is the key for diagnosis.

Classic cytologic features of papillary tumors, which have been reported in IPMT,12 were seldom seen in the current study. Although true papillae with fibrovascular cores are a typical feature of IPMT, we found none in the current series, nor did we find psammoma bodies, and only two cases showed prominent nuclear grooves. Cases in the current study with papillae were exclusively small three-dimensional micropapillary clusters, and were all associated with cellular atypia corresponding to malignant or borderline cases. Monolayered sheets were the predominant pattern in this series, and indeed the only one in benign cases. This finding is no surprise because it is a standard FNAB cytology presentation for papillary tumors of any origin, probably corresponding to the lining of true papillae.

Mucinous epithelium, with wide vacuolated cytoplasm, was found in most cases, but not in all. Loss of mucin production is a sign of dedifferentiation and probably accounts for the presence of nonmucinous epithelium in borderline and malignant cases. Moreover, the cytopathologist must be aware of the different types of epithelium that may be present in IPMT, described variously as pancreatobiliary, intestinal, or oncocytic.1 A distinctive eosinophilic, nonmucinous epithelium may be representative of an otherwise typical IPMT, as can be seen in Figure 3.

An additional difficulty that we believe has not been stressed enough in cytologic reports of IPMT is the contamination by gastrointestinal epithelium and mucus that often occurs in EUS-FNAB samples. Small amounts of mucus must be regarded with caution for this reason. When a transgastric FNAB is performed for lesions in the body and tail of the pancreas, the cytopathologist has to be alert to the normal appearance of the gastric mucosa, which has a honeycombed appearance and may bear some resemblance to neoplastic mucinous epithelium. However, tumoral cells are significantly taller and cytoplasms are wider. In cases without evident cytologic atypia, the combination of a high amount of mucin that is invariably present in benign IPMT and the characteristic mucinous epithelium will be diagnostic. Nevertheless, however, the possibility of confusion with normal gastric mucosa has to be considered in every case. Similarly, duodenal epithelium may resemble ductal epithelium and the eosinophilic component of IPMT described above. Typically, duodenal epithelium contains goblet cells, but these may also be present in IPMT2 (Fig. 3B). For this reason, when only nonmucinous epithelium was present, we considered it as neoplastic when significant atypia or evident micropapillary configuration was found. Obviously, benign-appearing nonmucinous epithelium may be a more frequent component of IPMT than our data suggest, but the lack of previous references does not support this possibility.

Diagnosis in cases with benign IPMT can be particularly difficult because, as can be observed in the current series, cellularity tends to be poor, without complete papillae, and mucin, although abundant, may be fluid and difficult to recognize microscopically. An accurate microscopic examination is mandatory to detect the highly characteristic mucinous epithelium, which can establish a diagnosis on its own. With regard to malignant cases, the classic cytologic features of malignancy are usually found.

Once a mucinous neoplasm has been identified, the distinction between IPMT and a mucinous adenocarcinoma or a mucinous cystic neoplasm is a matter of correlation with clinical and image data.12 In this regard, the great advantage of being present in the exploration room is that the cytopathologist can ascertain personally that the specimen is obtained from a dilated duct or from a cystic lesion connected to the ductal system. Otherwise, a diagnosis of “mucinous neoplasm” is appropriate, whereas a cytologic diagnosis of IPMT requires a specific clinicopathologic communication.

A cytologic diagnosis of IPMT through EUS-FNAB is feasible, at least as a clinically significant orientation. The papillary nature of the lesion may be not obvious, particularly in benign cases, and the epithelium may be nonmucinous, particularly in malignant cases. Contamination with normal gastrointestinal epithelium, which occurs frequently in EUS-FNAB procedures, is a potential diagnostic pitfall in benign IPMT.

REFERENCES

  1. Top of page
  2. Abstract
  3. MATERIALS AND METHODS
  4. RESULTS
  5. DISCUSSION
  6. REFERENCES
  • 1
    Klimstra DS, Adsay NV. Benign and malignant tumors of the pancreas. In: OdzeRD, GoldblumJR, CrawfordJM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Saunders, 2004: 699736.
  • 2
    Hamilton SR, Aaltonen LA. World Health Organisation classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon, France: IARC Press, 2000.
  • 3
    Doi R, Fujimoto K, Wada M, Imamura M. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery. 2002; 132: 8085.
  • 4
    Schmitz-Winnenthal FH, Z'graggen K, Volk C, Schmied BM, Buchler MW. Intraductal papillary mucinous tumors of the pancreas. Curr Gastroenterol Rep. 2003; 5: 133140.
  • 5
    Pellise M, Castells A, Gines A, et al. Clinical usefulness of KRAS mutational analysis in the diagnosis of pancreatic adenocarcinoma by means of endosonography-guided fine-needle aspiration biopsy. Aliment Pharmacol Ther. 2003; 17: 12991307.
  • 6
    Sugiyama M, Atomi Y, Saito M. Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography. Gastrointest Endosc. 1998; 48: 164171.
  • 7
    Kubo H, Chijiiwa Y, Akahoshi K, et al. Intraductal papillary-mucinous tumors of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol. 2001; 96: 14291434.
    Direct Link:
  • 8
    Aithal GP, Chen RYM, Cunningham JT, et al. Accuracy of endoscopic ultrasound for detection of intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc. 2002; 56: 701707.
  • 9
    Prasad SR, Sahani D, Nasser S, et al. Intraductal papillary mucinous tumors of the pancreas. Abdom Imaging. 2003; 28: 357365.
  • 10
    Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc. 2003; 58: 701706.
  • 11
    Dodd LG, Farrell TA, Layfield LJ. Mucinous cystic tumor of the pancreas: an analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features. Diagn Cytopathol. 1995; 12: 113119.
  • 12
    Centeno BA. Role of cytology in the diagnosis of cystic and intraductal papillary mucinous neoplasms. Gastrointest Endosc Clin North Am. 2002; 12: 697708.
  • 13
    Hara H, Suda K, Oyama T. Cytologic study of noninvasive intraductal papillary-mucinous carcinoma of the pancreas. Acta Cytol. 2002; 46: 519526.
  • 14
    Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol. 2003; 98: 15161524.
    Direct Link:
  • 15
    Recine M, Kaw M, Evans DB, Krishnamurthy S. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer (Cancer Cytopathol). 2004; 102: 9299.
  • 16
    Centeno BA, Warshaw AL, Mayo-Smith W, Southern JF, Lewandrowski K. Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol. 1997; 41: 972980.
  • 17
    Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004; 28: 241246.
  • 18
    Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002; 51: 717722.
  • 19
    Lewandrowski KB, Southern JF, Pins MR, Compton CC, Warshaw AL. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg. 1993; 217: 4147.
  • 20
    Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126: 13301336.
  • 21
    O' Toole D, Palazzo L, Hammel P, et al. Macrocystic pancreatic cystadenoma: the role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc. 2004; 59: 823829.